141 related articles for article (PubMed ID: 15965894)
1. Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis.
König P; Goldstein D; Poehlmann M; Rife D; Ge B; Hewett J
Pediatr Pulmonol; 2005 Aug; 40(2):105-8. PubMed ID: 15965894
[TBL] [Abstract][Full Text] [Related]
2. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
[TBL] [Abstract][Full Text] [Related]
3. Glucose intolerance in cystic fibrosis patients.
Lanng S
Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
[TBL] [Abstract][Full Text] [Related]
4. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
5. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
6. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
7. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment.
Mentore K; Froh DK; de Lange EE; Brookeman JR; Paget-Brown AO; Altes TA
Acad Radiol; 2005 Nov; 12(11):1423-9. PubMed ID: 16253854
[TBL] [Abstract][Full Text] [Related]
8. Clinical importance of cystic fibrosis-related diabetes.
Brennan AL; Geddes DM; Gyi KM; Baker EH
J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
Bogie AL; Towne D; Luckett PM; Abramo TJ; Wiebe RA
Pediatr Emerg Care; 2007 Jun; 23(6):355-61. PubMed ID: 17572517
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis-related diabetes in adults.
Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Chung WY; Gibney J; O'Shea D
Ir Med J; 2006 Mar; 99(3):83-6. PubMed ID: 16700261
[TBL] [Abstract][Full Text] [Related]
12. Demographics of glucose metabolism in cystic fibrosis.
van den Berg JM; Kouwenberg JM; Heijerman HG
J Cyst Fibros; 2009 Jul; 8(4):276-9. PubMed ID: 19467621
[TBL] [Abstract][Full Text] [Related]
13. Calpain 10 and development of diabetes mellitus in cystic fibrosis.
Derbel S; Doumaguet C; Hubert D; Mosnier-Pudar H; Grabar S; Chelly J; Bienvenu T
J Cyst Fibros; 2006 Jan; 5(1):47-51. PubMed ID: 16377260
[TBL] [Abstract][Full Text] [Related]
14. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
[TBL] [Abstract][Full Text] [Related]
15. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
[TBL] [Abstract][Full Text] [Related]
16. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma.
Salo D; Tuel M; Lavery RF; Reischel U; Lebowitz J; Moore T
J Emerg Med; 2006 Nov; 31(4):371-6. PubMed ID: 17046476
[TBL] [Abstract][Full Text] [Related]
17. Effect of albuterol on maximal exercise capacity in cystic fibrosis.
Serisier DJ; Coates AD; Bowler SD
Chest; 2007 Apr; 131(4):1181-7. PubMed ID: 17426226
[TBL] [Abstract][Full Text] [Related]
18. The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Strizek SJ; Colombo JL
Am J Respir Crit Care Med; 1996 Jul; 154(1):156-60. PubMed ID: 8680672
[TBL] [Abstract][Full Text] [Related]
19. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
20. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]